Allogene Therapeutics, Inc. (ALLO)

Allogene Therapeutics Employees

As of December 31, 2024, Allogene Therapeutics had 229 total employees, including 226 full-time and 3 part-time employees. The number of employees decreased by 4 or -1.72% compared to the previous year.

• Employees: 229
• Change (1Y): -4
• Growth (1Y): -1.72%
• Revenue / Employee: n/a
• Profits / Employee: -$925,830
• Market Cap: 568.57M

Employees History

Date	Employees	Change (1Y)	Growth (1Y)	Full-Time	Part-Time
Dec 31, 2024	229	-4	-1.72%	226	3
Dec 31, 2023	233	-128	-35.46%	232	1
Dec 31, 2022	361	51	16.45%	359	2
Sep 30, 2022	356	55	18.27%	356	0
Jun 30, 2022	344	59	20.70%	344	0
Mar 31, 2022	334	58	21.01%	334	0
Dec 31, 2021	310	45	16.98%	308	2
Sep 30, 2021	301	37	14.02%	301	0
Jun 30, 2021	285	49	20.76%	285	0
Mar 31, 2021	276	61	28.37%	276	0
Dec 31, 2020	265	59	28.64%	264	1
Sep 30, 2020	264	74	38.95%	264	0
Jun 30, 2020	236	62	35.63%	236	0
Mar 31, 2020	215	64	42.38%	215	0